Exacerbation in glycemic control by switching from subcutaneous dulaglutide injection to oral semaglutide administration in a patient with type 2 diabetes, who had undergone gastrectomy., Takebayashi K, Harasawa A, Miyake Y, Ujiie A, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Med J., 3, 303-307, 2024